The GLP aggregated and excerpted this blog/article from the Retraction Watch website:
The American Journal of Clinical Nutrition is retracting a paper that showed genetically engineered rice serves as an effective vitamin A supplement after a judge denied the first author’s motion for an injunction against the publisher.
The journal announced plans to retract the paper last year following allegations that the paper contained ethical mis-steps, such as not getting informed consent from parents of children eating the rice, and faking ethics approval documents.
Last July, first author Guangwen Tang at Tufts University filed a complaint and motion for preliminary injunction against the journal’s publisher, the American Society for Nutrition, to stop the retraction.
After an investigation, Tufts concluded that Tang had indeed breached ethical regulations, and banned her from conducting human research for two years. In addition, she would have to be supervised in order to conduct any future research. A Tufts University spokesperson commented:
“No questions were raised about the integrity of the study data, accuracy of the research results or safety of the research subjects. The decision to retract a paper is ultimately a matter between the journal and the authors, and we must respect an academic journal’s editorial process and decisions…
There was no evidence found of falsification or fabrication of the data that underlie the study’s primary findings. Those reviews did, however, determine that the research had not been conducted in full compliance with Tufts research policies and federal research regulations.'”
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Golden rice paper pulled after judge rules for journal